Articles Referencing SGYP
Positive Data from Synergy Pharma - Analyst Blog
5/24/2013, 12:29 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) recently announced positive results from a
multicenter trial which evaluated its pipeline candidate
plecanatide for treating patients suffering from... Read >>
Synergy Pharma Posts Wider Loss - Analyst Blog
5/15/2013, 12:21 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) reported a loss
of 24 cents per share in the first quarter of 2013, wider than the
year-ago loss of 13 cents and the Zacks Consensus Estimate of... Read >>
Synergy Pharma Prices Public Offering - Analyst Blog
4/12/2013, 4:06 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) recently priced
its public offering of 16.4 million shares of its common stock,
with an overallotment option for an additional 2.5 million
shares. ... Read >>
Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ
4/11/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active
The NASDAQ 100
Pre-Market Indicator is down -10.22 to 2,848.99. The total
Pre-Market volume is currently 12,832,717 shares traded.
The following are the
most active stocks for the... Read >>
Synergy Pharma to Raise Funds - Analyst Blog
4/10/2013, 6:10 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) recently
announced that it will be raising funds through an underwritten
public offering. Synergy Pharma intends to sell $90 million of its
common... Read >>
Synergy Posts Wider Loss - Analyst Blog
3/20/2013, 9:49 am from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) reported a loss
of 17 cents per share in the fourth quarter of 2012, wider than the
year-ago loss and the Zacks Consensus Estimate of a loss of... Read >>
Synergy Starts SP-333 Phase I Study - Analyst Blog
1/29/2013, 4:50 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) recently
initiated a phase Ib study on its inflammatory bowel disease (IBD)
candidate, SP-333. SP-333, a guanylate cyclase C (GC-C) agonist,... Read >>
Synergy/Callisto Merger Approved - Analyst Blog
1/17/2013, 4:40 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. 's ( SGYP ) stockholders
recently approved Synergy Pharma's merger with Callisto
Pharmaceuticals Inc. The deal was initially announced in Jul 2012
and later... Read >>
Positive Results on SGYP Candidate - Analyst Blog
1/3/2013, 4:30 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals ( SGYP )
recently presented positive results from a phase IIb/III study on
its chronic idiopathic constipation (CIC) candidate, plecanatide.
The study met its... Read >>
Company News for January 3, 2013 - Corporate Summary
1/3/2013, 9:06 am from Zacks.com in Investing, Business, Investing Ideas, Stocks
• Apple Inc. (NASDAQ: AAPL )
surged 3.2% after tech website The Next Web reported that the
company has already began tests for new version of iPhone and iOS
software
... Read >>
Pipeline Progress at Synergy Pharma - Analyst Blog
12/31/2012, 1:02 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals ( SGYP )
recently initiated a phase IIb study with plecanatide for the
treatment of patients suffering from constipation-predominant
irritable bowel syndrome... Read >>